Budapest, Hungary

Istvan Erczi

This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszergyar. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Istvan Erczi. Retrieved from https://idiyas.com/inventor/istvan-erczi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Istvan Erczi: Pharmaceutical Invention in Budapest

Introduction

Istvan Erczi is an inventor associated with Budapest, Hungary, and Biogal Gyogyszergyar. His recorded patent work concerns aminoguanidine derivatives and their potential pharmaceutical applications.

Latest Patents

Erczi is associated with 1 patent, titled “Aminoguanidine Compounds, Their Compositions and Pharmaceutical Uses.” The invention describes aminoguanidine derivatives with substituents that may include hydrogen, halogen, C₁–₄ alkyl, nitro, trifluoromethyl, or C₁–₄ alkoxy groups. It also concerns compositions containing these compounds and their pharmaceutical uses.

Career Highlights

The available information connects Erczi’s inventive work with Biogal Gyogyszergyar and pharmaceutical research. His patent reflects an effort to develop and describe new chemical compounds for potential medicinal use.

Collaborations

Erczi’s listed coworkers include Gyorgy Rabloczky and Andras Varro. Their names are associated with the professional context provided for his work.

Conclusion

Istvan Erczi’s recorded patent highlights his contribution to pharmaceutical innovation through aminoguanidine compounds, their compositions, and their potential uses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…